PMID: 30787986Feb 23, 2019Paper

Efficacy of subcutaneous immunotherapy in a mouse model of Humulus pollen-induced allergic asthma

American Journal of Translational Research
Rui Kong, Jia Yin

Abstract

The aim of this study was to evaluate the therapeutic effect of subcutaneous injection of high-dose of Humulus pollen allergen on a mouse model of allergic asthma. Humulus pollen-sensitized mice received either regular subcutaneous injections of Humulus pollen allergen extract or control treatment were sacrificed. Airway responsiveness, pulmonary inflammatory cell infiltration, serum cytokine secretion and serum immunoglobulin E (IgE) and G2a (IgG2a) levels were measured. Our results showed that subcutaneous immunotherapy with high-dose of Humulus pollen allergen could obviously relieve the symptoms and improve the pulmonary function in mice with allergic asthma. It also elevated serum IgE and IgG level compared with model group. The Humulus pollen allergens could be identified in serum and the molecular weight of serum proteins that had the maximum binding to allergen were ~25 kDa and ~38 kDa in 7 cases (70%) and 6 cases (60%), respectively. Subcutaneous immunotherapy (high-dose) could effectively alleviate airway hyperresponsiveness and reduce airway inflammatory infiltration in allergic asthmatic mice.

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.